Transcatheter Leadless Pacemaker for the Treatment of Vasovagal Syncope
Author Department
Cardiology; Medicine
Document Type
Article, Peer-reviewed
Publication Date
5-2023
Abstract
Vasovagal syncope (VVS) is largely a benign condition focused on patient education, lifestyle modification, and avoidance of triggers. However, a subset of patients may benefit from permanent pacemaker placement. Commonly, patients with VVS are younger and those requiring pacing have symptoms associated with severe cardioinhibitory syncope. With the advent of leadless pacemaker systems, a lot of the risks associated with traditional transvenous pacemaker systems are mitigated. In this manuscript, we provide a comprehensive review of the data available for the treatment of cardioinhibitory vasovagal syncope using leadless pacemaker systems.
Recommended Citation
Kadado AJ, Gobeil K, Motta J, Chalhoub F. Transcatheter Leadless Pacemaker for the Treatment of Vasovagal Syncope. Crit Pathw Cardiol. 2023 May 31. doi: 10.1097/HPC.0000000000000325. Epub ahead of print.
PMID
37249900